ET-traps
ET-traps
  • ET-traps
  • ABOUT
  • TECHNOLOGY
  • ADVANTAGES
  • CLINICAL APPLICATIONS
  • INVESTORS
  • TEAM
  • NEWS
  • CONTACT
  • SCIENTIFIC PUBLICATIONS
    • ET-traps
    • ABOUT
    • TECHNOLOGY
    • ADVANTAGES
    • CLINICAL APPLICATIONS
    • INVESTORS
    • TEAM
    • NEWS
    • CONTACT
    • SCIENTIFIC PUBLICATIONS
  • ET-traps
  • ABOUT
  • TECHNOLOGY
  • ADVANTAGES
  • CLINICAL APPLICATIONS
  • INVESTORS
  • TEAM
  • NEWS
  • CONTACT
  • SCIENTIFIC PUBLICATIONS

Welcome to ET-traps Limited

Welcome to ET-traps LimitedWelcome to ET-traps LimitedWelcome to ET-traps Limited

Novel therapeutics 

Contact Us

Welcome to ET-traps Limited

Welcome to ET-traps LimitedWelcome to ET-traps LimitedWelcome to ET-traps Limited

Novel therapeutics 

Contact Us

What We Do

image476

Commitment to Innovation

ET-traps therapeutic targets pathologically elevated endothelin-1 levels in the body bringing endothelin-1 and various markers of heart and kidney function back to non-disease levels without side effects.

image477

Drug Development

We believe we have discovered a potent therapy for cardiovascular disease, chronic kidney disease and other diseases like diabetes and neurological disorders that are associated with pathologically elevated ET-1 levels with a low cost, low dosage drug with no side effects.


Copyright © 2021  ET-traps  Limited- All Rights Reserved.

  • ABOUT
  • TECHNOLOGY
  • ADVANTAGES
  • CLINICAL APPLICATIONS
  • INVESTORS
  • TEAM
  • NEWS
  • CONTACT
  • SCIENTIFIC PUBLICATIONS